Implications on glycobiological aspects of tumor hypoxia in breast ductal carcinoma in situ

Medical Molecular Morphology

Volumn 46, Issue 2, 2013, Pages 92-96

  Rêgo, Moacyr Jesus Barreto De Melo ^a   Vieira De Mello, Gabriela Souto ^a   Da Silva Santos, Carlos André ^a   Chammas, Roger ^b   Beltrão, Eduardo Isidoro Carneiro ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

DCIS; Galectins; Hypoxia; Immunohistochemistry; Lectin histochemistry

Indexed keywords

CONCANAVALIN A; GALECTIN 1; GALECTIN 3; LECTIN; PEANUT AGGLUTININ; ULEX EUROPAEUS AGGLUTININ; WHEAT GERM AGGLUTININ;

ARTICLE; CYTOPLASM; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR HYPOXIA;

ANOXIA; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; GALECTIN 1; GALECTIN 3; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LECTINS; TUMOR MICROENVIRONMENT;

EID: 84879110676     PISSN: 18601480     EISSN: 18601499     Source Type: Journal    
DOI: 10.1007/s00795-013-0013-4     Document Type: Article

References (23)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) GLOBOCAN 2008 v1.2, Cancer incidence and mortality worldwide: IARC Cancerbase No. 10 [Internet]. International Agency for Research on Cancer, Lyon
2. Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G, Yankaskas BC, Rosenberg R, Carney PA, Kerlikowske K, Taplin SH, Urban N, Geller BM (2002) Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 94:1546-1554
3. Ruan K, Song G, Ouyang G (2009) Role of hypoxia in the hallmarks of human cancer. J Cell Biochem 107(6):1053-1062
4. Bussolati G, Bongiovanni M, Cassoni P, Sapino A (2000) Assessment of necrosis and hypoxia in ductal carcinoma in situ of the breast: basis for a new classification. Virchows Arch 437(4):360-364
5. Cosse JP, Michiels C (2008) Tumour hypoxia affects the responsiveness of cancer cells to chemotherapy and promotes cancer progression. Anticancer Agents Med Chem 8:790-797
6. Moeller BJ, Richardson RA, Dewhirst MW (2007) Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment. Cancer Metastasis Rev 26:241-248
7. Shirato K, Nakajima K, Korekane H, Takamatsu S, Gao C, Angata T, Ohtsubo K, Taniguchi N (2011) Hypoxic regulation of glycosylation via the N acetylglucosamine cycle. J Clin Biochem Nutr 48(1):20-25
8. TaniguchI N (2009) From the gamma-glutamyl cycle to the glycan cycle: a road with many turns and pleasant surprises. J Biol Chem 284(50):34469-34478
9. Vasta GR (2012) Galectins as pattern recognition receptors: structure, function and evolution. Adv Exp Med Biol 946:21-36
10. Ghazarian H, Idoni B, Oppenheimer SB (2011) A glycobiology review: carbohydrates, lectins and implications in cancer therapeutics. Acta Histochem 113:236-254
11. Olbryt M, Jarzab M, Jazowiecka-rakus J, Simek K, Szala S, Sochanik A (2006) Gene expression profile of B 16(F10) murine melanoma cells exposed to hypoxic conditions in vitro. Gene Expr 13(3):191-203
12. Le QT, Shi G, Cao H, Nelson DW, Wang Y, Chen EY, Zhao S, Kong C, Richardson D, O'Byrne KJ, Giaccia AJ, Koong AC (2005) Galectin-1: a link between tumor hypoxia and tumor immune privilege. J Clin Oncol 23(35):8932-8941
13. Goetz JA, Mechref Y, Kang P, Jeng MH, Novotny MV (2009) Glycomic profiling of invasive and non-invasive breast cancer cells. Glycoconj J 26:117-131
14. Powlesland AS, Hitchen PG, Parry S, Graham SA, Barrio MM, Elola MT, Mordoh J, Dell A, Drickamer K, Taylor ME (2009) Targeted glycoproteomic identification of cancer cell glycosylation. Glycobiol 19:899-909
15. Ono M, Hakomori S (2004) Glycosylation defining cancer cell motility and invasiveness. Glycoconj J 20:71-78
16. Shimma Y, Jigami Y (2004) Expression of human glycosyltransferase genes in yeast as a toll for enzimatic synthesis of sugar chain. Glycoconj J 21:75-78
17. Shinji G, Chihiro S, Jun Y, Reiji K, Ken K (2007) Hypoxia-enhanced expression of free deaminoneuraminic acid in human cancer cells. Biochem Biophys Res Commun 357(2):7537-7542
18. Koike T, Kimura N, MIyazaki K, Yabuta T, Kumamoto K, Takenoshita S, Chen J et al (2004) Hypoxia induces adhesion molecules on cancer cells: a missing link between warburg effect and induction of selectin-ligand carbohydrates. Proc Natl Acad Sci USA 101(21):8132-8137
19. Suzuki O, Nozawa Y, Kawaguchi T, Abe M (2003) Alpha-2,6-sialylation of L-PHA reactive oligosaccharides and expression of N-Acetyl-glucosaminyl transferase V in human diffuse large B cell lymphoma. Oncol Rep 10(6):1759-1764
20. Yin J, Hashimoto A, Izawa M, Miyazaki K, Chen GY, Takematsu H, Kozutsumi Y, Suzuki A, Furuhata K, Cheng FL, Lin CH, Sato C, Kitajima K, Kannagi R (2006) Hypoxic culture induces expression of sialin, a sialic acid transporter, and cancer-associated gangliosides containing non-human sialic acid on human cancer cells. Cancer Res 66(6):2937-2945
21. Varki A, Kannagi R, Toole BP (2009) Changes in glycosylation Cancer. In: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME (eds) Essentials of glycobiology. Cold Spring Harbor Laboratory Press, New York. http://www.ncbi.nlm.nih.gov/books/NBK1963/
22. Jung EJ, Moon HG, Cho BI, Jeong CY, Joo YT, Lee YJ, Hong SC, Choi SK, Ha WS, Kim JW, Lee CW, Lee JS, Park ST (2007) Galectin-1 expression in cancer-associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer. Int J Cancer 120(11):2331-2338
23. Akahani S, Nangia-Makker P, Inohara H, Kim HR, Raz A (1997) Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res 57(23):5272-5276